The study suggests a need to revise guidelines that suggest following up GPs to prevent GBC, which were based on low levels of evidence.
-
Gallbladder polyps may not require surveillance -
Regulators from around the world agree to cooperate on observational research during COVID-19.
-
Experts say a cautious, measured approach to relaxing lockdown measures is required to protect the most vulnerable and support the health service.
-
Stories you need to know about Wednesday.
-
Walking and cycling should be encouraged during the post-lockdown period.
-
President Trump’s letter says he will permanently freeze US funding to the WHO unless there are substantive changes within the next 30 days.
-
Participants will be randomly assigned to one of four groups: high-dose, mid-dose, low-dose chloroquine or placebo.
-
Metastatic CRPC: FDA approves rucaparib for previously treated patients with BRCA mutations First-in-class treatment gets the nod.
-
Metastatic HR+ breast cancer: subgroup OS benefit with CDK4/6 inhibitors plus ET Meta-analysis examines 6 phase 2/3 RCTs.
-
Secondary ALL: OS is worse than in de novo disease across all age groups Survival in ALL worsens with increasing age.
-
EMA recommends new handling measures for leuprorelin.
-
NSCLC: low-dose erlotinib shows benefit in older patients with frailty Little is known about EGFR-TKI efficacy in this patient population.
-
Stories you need to know about Tuesday.
-
HCC: checkpoint inhibitor/VEGF inhibitor combo shows promise VEGF has been linked to progression, but can play a role in immunosuppression.